Comparative Analysis of Varicella Complications in Pediatric Hospitalized Patients Before and After the COVID-19 Pandemic

Document Type : original article

Authors

1 Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Department of Pediatric Diseases, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Background: Chickenpox is a common viral illness in children, typically mild, but it can lead to severe complications and even death. The coronavirus disease 2019 (COVID-19) pandemic and related social, healthcare, and environmental changes may have altered disease patterns and outcomes.
Methods: This retrospective cross-sectional study examined hospitalization trends and complications in 390 children under 18 years admitted with chickenpox between 2017 and 2024 (1396–1403). Demographics, clinical complications, treatment interventions, and discharge outcomes were extracted from the Hospital Information System (HIS) and analyzed using SPSS v26.
Results: Before the pandemic, hospitalizations and complications were infrequent, reflecting generally mild disease. After the pandemic, both the number of hospitalized children and the severity of complications increased markedly, with nearly half of patients in 2023 (1402) experiencing significant complications. Common complications included cellulitis (21%), pneumonia (14%), and arthritis (3.3%). Approximately 15% required intensive care, with an average intensive care unit (ICU) stay of 3.96 days, and several children developed rare but serious conditions such as toxic shock syndrome. Notably, 10% had underlying immunodeficiency, increasing their vulnerability.
Conclusion: These findings highlight a concerning post-pandemic shift, emphasizing the human cost of delayed vaccination, healthcare access challenges, and environmental and viral factors. Early identification of high-risk children, vigilant clinical monitoring, and strengthened preventive measures are essential to reduce morbidity and mortality, safeguarding the well-being of vulnerable pediatric populations.

Keywords


  1. Heininger U, Seward JF. Varicella. The Lancet. 2006 Oct 14;368(9544):1365-76.
  2. Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nature reviews Disease primers. 2015 Jul 2;1(1):15016.
  3. Seward JF, Marin M, Vázquez M. Varicella vaccine effectiveness in the US vaccination program: a review. The Journal of infectious diseases. 2008 Mar 1:S82-9.
  4. Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics. 2008 Sep 1;122(3):e744-51.
  5. Wutzler P, Bonanni P, Burgess M, Gershon A, Sáfadi MA, Casabona G. Varicella vaccination-the global experience. Expert review of vaccines. 2017 Aug 3;16(8):833-43.
  6. Marcum ZA, Jain P, Embry A, Arakaki B, Estevez I, Viscidi E. Incidence of herpes zoster and postherpetic neuralgia and herpes zoster vaccination uptake in a US administrative claims database. InOpen Forum Infectious Diseases 2024 May (Vol. 11, No. 5, p. ofae211). US: Oxford University Press.
  7. Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Archives of disease in childhood. 2007 Dec 1;92(12):1062-6.
  8. Shah HA, Meiwald A, Perera C, Casabona G, Richmond P, Jamet N. Global prevalence of varicella-associated complications: a systematic review and meta-analysis. Infectious diseases and therapy. 2024 Jan;13(1):79-103.
  9. Snoeck R, Andrei G, De Clercq E. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs. 1999 Feb;57(2):187-206.
  10. Pietrzak M, Pokorska-Śpiewak M. Impact of COVID-19 pandemic on the clinical course and complications of Varicella—A Retrospective Cohort Study. Pediatric Reports. 2024 Jun 4;16(2):451-60.
  11. Ratzan SC. Vaccine Communication in a Pandemic. 2023.
  12. Duus LS, Johansen ND, Modin D, Janstrup KH, Nealon J, Samson S, et al. Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trial. Respiratory investigation. 2025 Nov 1;63(6):1309-15.
  13. Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics. 2001 Nov 1;108(5):e79-.
  14. Agosti M, Morlacchi L, Tandoi F, Bossi A. 74th Congress of the Italian Society of Pediatrics. Pediatrics. 2018 Jun;12:16.
  15. Monge S, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, et al. Effectiveness of XBB. 1.5 monovalent COVID‐19 vaccines during a period of XBB. 1.5 dominance in EU/EEA countries, October to November 2023: a VEBIS‐EHR network study. Influenza and Other Respiratory Viruses. 2024 Apr;18(4):e13292.
  16. Sheybani F, Haddad M, Shirazinia M. Epidemiology and etiology of community-acquired CNS infections in Iran: a narrative review. Future Neurology. 2023 Dec 1;18(4):FNL73.
  17. Ansharieta R, Effendi MH, Plumeriastuti H. Detection of multidrug-resistant (MDR) Escherichia coli isolated from raw milk in East Java Province, Indonesia. Indian Journal of Forensic Medicine & Toxicology. 2020;14(4):2287-91.
  18. Talebi-Taher M, Kashanian M, Khalili K. Seroprevalence of varicella-zoster virus among pregnant women in two teaching hospitals, Tehran, Iran. Iranian journal of microbiology. 2014 Feb;6(1):37.
  19. Wang J, Xu Z, Gao Q. Varicella outbreaks in schools and kindergartens in Shanghai, China from 2011 to 2020. PLoS One. 2022 Jun 30;17(6):e0270630.
  20. Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola L, et al. Varicella in infants after implementation of the US varicella vaccination program. Pediatrics. 2011 Dec 1;128(6):1071-7.
  21. Widgren K. The Epidemiology of Varicella Zoster Virus Disease in Sweden Before and After Vaccination. Karolinska Institutet (Sweden); 2021.
  22. Helmuth IG, Poulsen A, Suppli CH, Mølbak K. Varicella in Europe—a review of the epidemiology and experience with vaccination. Vaccine. 2015 May 15;33(21):2406-13.
  23. Phillips A, Glover C, Leeb A, Cashman P, Fathima P, Crawford N, et al. Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance. BMJ open. 2021 Mar 1;11(3):e043880.
  24. Kuter BA, Matthews HO, Shinefield HE, Black S, Dennehy P, Watson B, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. The Pediatric infectious disease journal. 2004 Feb 1;23(2):132-7.
  25. Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, et al. Varicella vaccination in Europe–taking the practical approach. BMC medicine. 2009 May 28;7(1):26.
  26. Parri N, Lenge M, Buonsenso D. Children with Covid-19 in pediatric emergency departments in Italy. New England Journal of Medicine. 2020 Jul 9;383(2):187-90.